Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookStandard Treatment Guidelines for Health Centers (First Edition) - Ethiopia (DACA; 2004; 240 pages)
View the documentACKNOWLEDGEMENTS
View the documentFOREWORD
View the documentCHAPTER 1. INTRODUCTION
Open this folder and view contentsCHAPTER 2. INFECTIOUS DISEASES
close this folderCHAPTER 3. SEXUALLY TRANSMITTED DISEASES
View the documentGENITAL ULCER SYNDROME
View the documentINGUINAL BUBO
View the documentLOWER ABDOMINAL PAIN SYNDROME
View the documentSCROTAL SWELLING
View the documentURETHRAL DISCHARGE SYNDROME
View the documentVAGINAL DISCHARGE SYNDROME
Open this folder and view contentsCHAPTER 4. COMMON SKIN PROBLEMS
Open this folder and view contentsCHAPTER 5. NON-INFECTIOUS DISEASES
Open this folder and view contentsCHAPTER 6. OBSTETRICS AND GYNECOLOGICAL CONDITIONS
Open this folder and view contentsCHAPTER 7. PEDIATRIC DISEASES
Open this folder and view contentsCHAPTER 8. /EMERGENCY CONDITIONS
View the documentANNEXES
 

VAGINAL DISCHARGE SYNDROME

Vaginal discharge syndrome is diagnosed when a woman complains of vaginal discharge that is in excess of the usual or if it causes itching or discomfort. Women develop abnormal vaginal discharge if they have either vaginitis (infection of the vagina) or cervicitis (infection of the cervix), or both. Unfortunately, it is not easy to distinguish between cervicitis and vaginitis, especially when an internal examination is not possible. Often, it may be useful to treat the patient for both cervicitis and vaginitis if the diagnosis cannot be established for certain.

Treatment

Non-Drug treatment:

Provide education, promote the use of condoms and ask the patient to return in seven days if symptoms have not improved.

Drug Treatment

Ciprofloxacin, 500 mg p.o in a single dose

S/E: mild GI upset; rash and pruritus; hypersensititvity reactions including fever, joint pain, urticaria. Discontinue the drug if psychiatric. Neurological or severe hypersensitivity reactions occur.

C/I: renal impairment.

Dosage forms: Intra-venous infusion (as lactate) 2mg/ml in 50 ml and 100 ml bottle, Tablet (as hydrochloride), 250 mg.


OR

Spectinomycin, 2 gm by deep i.m. injection as a single dose.

(For S/E and dosage forms, see page 71).


PLUS

Doxycycline, 100 mg p.o. b.i.d. for 7 days.

(For S/E, C/I and dosage forms, see page 21).


OR

Metronidazole, 500 mg p.o. b.i.d. for 10 days.

(For S/E, C/I and dosage forms, see page 12)

to previous sectionto next section

Please provide your feedback English  |  French